Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 6.33% vs -11.53% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 40.09% vs 0.28% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -48.32% vs -14.86% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 18.44% vs -17.58% in Mar 2024
Compare Profit and Loss Results of Novartis India
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
356.00
1,859.00
-1,503.00
-80.85%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
356.00
1,859.00
-1,503.00
-80.85%
Expenditure (Ex Depriciation)
Stock Adjustments
3.00
-45.00
48.00
106.67%
Raw Materials Consumed
199.00
882.00
-683.00
-77.44%
Power & Fuel Cost
0.00
168.00
-168.00
-100.00%
Employee Cost
18.00
242.00
-224.00
-92.56%
Operating Expenses
8.00
141.00
-133.00
-94.33%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
10.00
44.00
-34.00
-77.27%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
9.00
26.00
-17.00
-65.38%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
264.00
1,531.00
-1,267.00
-82.76%
Operating Profit (PBDIT) excl Other Income
91.00
328.00
-237.00
-72.26%
Other Income
41.00
5.00
36.00
720.00%
Operating Profit (PBDIT)
133.00
333.00
-200.00
-60.06%
Interest
0.00
75.00
-75.00
-100.00%
Profit before Depriciation and Tax
132.00
258.00
-126.00
-48.84%
Depreciation
2.00
134.00
-132.00
-98.51%
Profit Before Taxation & Exceptional Items
130.00
123.00
7.00
5.69%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
130.00
123.00
7.00
5.69%
Provision for Tax
29.00
33.00
-4.00
-12.12%
Profit After Tax
100.00
90.00
10.00
11.11%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
728.00
924.00
-196.00
-21.21%
Profit Available for appropriations
829.00
1,014.00
-185.00
-18.24%
Appropriations
829.00
1,014.00
-185.00
-18.24%
Equity Dividend (%)
500%
40%
460.00
Earnings Per Share
40.87
7.37
33.50
454.55%
Profit And Loss - Net Sales
Net Sales 356.27 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 6.33% vs -11.53% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 91.42 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 40.09% vs 0.28% in Mar 2024
Profit And Loss - Interest
Interest 0.77 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -48.32% vs -14.86% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 100.90 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 18.44% vs -17.58% in Mar 2024






